ReviewRSC advances2023

Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review.

Mostafa A Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.